Sorrento Therapeutics has patented an implantable delivery device with nano and microstructures to deliver bioactive agents without triggering an immune response. The device’s unique design allows for precise and efficient delivery to subjects in need. GlobalData’s report on Sorrento Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Sorrento Therapeutics, Personalized cancer vaccines was a key innovation area identified from patents. Sorrento Therapeutics's grant share as of April 2024 was 35%. Grant share is based on the ratio of number of grants to total number of patents.
Implantable device for delivering bioactive agents without immune response
A newly granted patent (Publication Number: US11925712B2) discloses a fully implantable delivery device designed for the delivery of bioactive agents to a subject. The device features a wall with a surface containing a unique combination of nanostructures and microstructures arranged in a fractal dimension greater than about 1. These structures are crucial for the controlled release of bioactive agents within specific dimensions and spacing parameters, ensuring effective delivery to the subject.
Furthermore, the implantable delivery device includes a reservoir for containing the bioactive agent and is configured to interact with the surrounding tissue near the implantation site. The device's surface characteristics, including the presence of nanostructures with specific dimensions and spacing, play a significant role in determining the effectiveness of the delivery process. With features like an effective shear modulus range and aspect ratios for the nanostructures and microstructures, this patented device showcases a novel approach to targeted and controlled delivery of bioactive agents within the subject's body, promising advancements in the field of implantable drug delivery systems.
To know more about GlobalData’s detailed insights on Sorrento Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
